Clinical Trials › NCT04387734
Active, Not RecruitingPhase 4
Effects of Ocrevus in Relapsing Multiple Sclerosis
Sponsored by Georgia State University
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 60
Target enrollment
1
U.S. states
Feb 2021
Start date
Apr 2026
Expected completion
Interventions / Treatments
OcrelizumabPlatform
Conditions studied
Relapsing Multiple Sclerosis
Where this trial is running (2 sites)
Georgia2 sites
Atlanta · Atlanta
MS centers in Georgia
Compare treatment centers near a trial site by center type, providers and trials.
View Georgia centers